Looks great. This will open up oraline to new markets as many companies refused to use oraline IV as it didn't test for the complete suite of drugs required. Onwards and upwards........
SBN Price at posting:
0.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
